FindTrial
Sign In

The mechanism and clinical translational study of PHGDH regulating tumor stemness in the microenvironment of early gastric cancer

The mechanism and clinical translational study of PHGDH regulating tumor stemness in the microenvironment of early gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107095
Enrollment
Unknown
Registered
2025-08-04
Start date
2025-08-04
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

Early gastric cancer group:None
Healthy group:None

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.The surgical pathology is consistent with the diagnostic criteria for early gastric cancer. 2.Agree to participate in this study.

Exclusion criteria

Exclusion criteria: 1.Patients with concurrent other malignant tumors or a history of other malignant tumors; 2.Patients with gastric tumors that are metastatic tumors; 3.Patients who received neoadjuvant therapy before surgery;

Design outcomes

Primary

MeasureTime frame
Expression level of PHGDH in plasma;—

Countries

China

Contacts

Public ContactMa Yongchen

Peking University First Hospital

yongchenma@bjmu.edu.cn+86 155 0111 7699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026